- CA$5.58bn
- CA$5.75bn
- $1.66bn
- 81
- 60
- 84
- 88
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 946 | 554 | 1,483 | 2,353 | 1,663 |
Cost of Revenue | |||||
Gross Profit | 617 | 258 | 1,062 | 1,833 | 1,128 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,057 | 1,500 | 852 | 1,065 | 1,109 |
Operating Profit | -111 | -946 | 631 | 1,288 | 554 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -168 | -892 | 336 | 1,208 | 567 |
Provision for Income Taxes | |||||
Net Income After Taxes | -204 | -693 | 234 | 914 | 456 |
Net Income Before Extraordinary Items | |||||
Net Income | -204 | -693 | 234 | 914 | 456 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -204 | -693 | 234 | 914 | 456 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.092 | -0.484 | 0.94 | 3.29 | 2.09 |
Dividends per Share |